Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP1/E, at very low doses, is sufficient to ameliorate PCOS-associated metabolic alterations Since GLP1/E was superior to any other compound in terms of improvement of metabolic traits, we next assessed the metabolic efficacy of very low doses of this multi-agonist in our metabolically dysregulated PCOS model
Guglielmi V, Bettini S, Sbraccia P, Busetto L, Pellegrini M, Yumuk V, Colao AM, El Ghoch M, Muscogiuri G
Lim DM, Park KY, Hwang WM, Kim JY, Kim BJ
Early research showed promising results, laying the foundation for further development
JCI Insight 3 , 93936 (2018)
Compared to placebo control, BPC significantly bettered recovery parameters
US$ 21.58
US$ 27.94
US$ 27.80
